The approval was based on data from 3 phase 3 trials which compared the efficacy of different dosing regimens of ...

Targeted prevention strategies and increased public awareness and vaccination coverage are needed to reduce the significant ...

High-dose influenza vaccine is associated with a more robust humoral response in patients with heart failure and history of myocardial infarction. Among patients with heart failure (HF) or previous ...

After grave missteps in the COVID-19 pandemic, the World Health Organization revisited the science and now confirms that many respiratory viruses are inhaled as airborne particles. The new framework ...

Higher intravenous ketamine doses do not outperform standard doses for treatment resistant depression. Intravenous (IV) ketamine for treatment resistant depression is effective at lower doses of 0.2 ...

In pediatric patients hospitalized with severe acute COVID-19, those with immunocompromising conditions had worse outcomes despite having similar disease severity relative to non-immunocompromised ...

Patients with advanced cancer receiving outpatient palliative care preferred telehealth over in-person visits even after the COVID-19 pandemic ended. Even after the SARS-CoV-2 vaccine against COVID-19 ...

Pregnant patients should discontinue use of thiopurines if they develop intrahepatic cholestasis of pregnancy. The use of thiopurines (eg, azathioprine, 6-mercaptopurine, and 6-thioguanine) by ...

SARS-CoV-2 antibody levels may be a correlate for immunity against COVID-19 infection and help determine the optimal timing of booster receipt. Serologic testing may allow individual-level assessment ...

Ensifentrine for Maintenance Treatment of COPD PDUFA date: June 26, 2024 Ensifentrine is a first-in-class, dual phosphodiesterase 3 and 4 inhibitor with combined bronchodilator and anti-inflammatory ...